+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Innovations in Cell, Gene, and Protein Therapies, Regenerative Medicine, Synthetic Biology, Epitranscriptomics, and CRISPR Editing

  • ID: 4763865
  • Report
  • 15 pages
  • Frost & Sullivan
1 of 3

FEATURED COMPANIES

  • Achieve Life Sciences
  • Cartherics
  • Horizon Pharma
  • Mammoth Biosciences
  • Neurocrine Biosciences
  • Paragonix Technologies
  • MORE

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) details technology innovations across cell and gene therapies, regenerative medicine, synthetic biology, epitranscriptomics, CRISPR editing, biological computing, multiplexed assay and liquid biopsy platforms. It also comprises emerging developments across mass spectrometry, vaccines, protein therapies, transplantation techniques, small molecule, and organ-on-a-chip technologies.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Achieve Life Sciences
  • Cartherics
  • Horizon Pharma
  • Mammoth Biosciences
  • Neurocrine Biosciences
  • Paragonix Technologies
  • MORE

1. Advances in Cell, Gene, and Protein Therapies, Regenerative Medicine, Synthetic Biology, Epitranscriptomics, and CRISPR Editing

  • Cartherics
  • Immuno-therapy
  • Cell Therapies
  • Cynata Therapeutics
  • Mesoblast
  • Orthocell
  • AMSilk
  • VLPbio
  • David H. Koch Institute for Integrative Cancer Research at MIT
  • Gotham Therapeutics
  • Beam Therapeutics
  • IQVIA
  • Microsoft
  • OMass Therapeutics
  • Nightstar Therapeutics
  • University of Minnesota
  • SpeeDx Diagnostics
  • Medicago
  • Mammoth Biosciences
  • Guardant Health
  • Horizon Pharma
  • Paragonix Technologies
  • Immunomedics
  • Achieve Life Sciences
  • Neurocrine Biosciences
  • InSphero
  • Bio-Rad
  • Key Contacts
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AMSilk
  • Achieve Life Sciences
  • Beam Therapeutics
  • Bio-Rad
  • Cartherics
  • Cynata Therapeutics
  • David H. Koch Institute for Integrative Cancer Research at MIT
  • Gotham Therapeutics
  • Guardant Health
  • Horizon Pharma
  • IQVIA
  • Immunomedics
  • InSphero
  • Mammoth Biosciences
  • Medicago
  • Mesoblast
  • Microsoft
  • Neurocrine Biosciences
  • Nightstar Therapeutics
  • OMass Therapeutics
  • Orthocell
  • Paragonix Technologies
  • SpeeDx Diagnostics
  • University of Minnesota
  • VLPbio
Note: Product cover images may vary from those shown
Adroll
adroll